Vaxcyte, Inc. (PCVX) Stock Price History
Historical prices from 2020 to 2026
Loading 10-year price history...
PCVX Historical Performance
Short-Term Returns
PCVX Stock Price Trajectory (2020–2026)
As of May 8, 2026, Vaxcyte, Inc. (PCVX) trades at $51.48, representing a +77.5% return over the past year. The stock has delivered a +191.8% total return over five years (+23.9% CAGR), reflecting significant long-term value creation.
The stock reached its all-time high of $121.06 on September 19, 2024. From this peak, PCVX has corrected -57.5%, currently trading 11% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers PFE (+16.2% 1Y), MRK (+41.9% 1Y), and GSK (+35.9% 1Y), PCVX has outperformed the peer group average. Compare PCVX vs PFE →
PCVX Historical Price Data (2025–2026)
Showing 30 of 1,484 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 54.63 | 55.02 | 48.49 | 51.48 | 5.27M | -9.84% |
| 2026-05-06 | 56.20 | 57.33 | 55.08 | 57.10 | 1.55M | +2.53% |
| 2026-05-05 | 59.02 | 59.39 | 54.13 | 55.69 | 916K | -4.79% |
| 2026-05-04 | 56.65 | 59.00 | 56.65 | 58.49 | 1.19M | +2.74% |
| 2026-05-01 | 57.26 | 57.80 | 56.22 | 56.93 | 694K | -0.54% |
| 2026-04-30 | 57.95 | 58.32 | 56.13 | 57.24 | 1.88M | -0.14% |
| 2026-04-29 | 57.98 | 58.54 | 56.60 | 57.32 | 871K | -2.40% |
| 2026-04-28 | 60.23 | 60.63 | 58.27 | 58.73 | 805K | -1.66% |
| 2026-04-27 | 59.08 | 60.70 | 59.08 | 59.72 | 954K | +0.39% |
| 2026-04-24 | 60.64 | 61.40 | 58.65 | 59.49 | 838K | -2.11% |
| 2026-04-23 | 60.46 | 61.00 | 59.20 | 60.77 | 916K | -0.07% |
| 2026-04-22 | 61.01 | 61.82 | 60.27 | 60.81 | 746K | +0.43% |
| 2026-04-21 | 61.30 | 62.10 | 60.00 | 60.55 | 970K | -2.32% |
| 2026-04-20 | 62.57 | 63.05 | 61.53 | 61.99 | 930K | -0.58% |
| 2026-04-17 | 62.91 | 63.31 | 61.33 | 62.35 | 1.09M | +0.24% |
| 2026-04-16 | 60.24 | 62.87 | 60.00 | 62.20 | 1.35M | +2.89% |
| 2026-04-15 | 62.76 | 62.84 | 60.19 | 60.45 | 1.04M | -3.68% |
| 2026-04-14 | 62.12 | 63.18 | 61.81 | 62.76 | 983K | +1.64% |
| 2026-04-13 | 61.42 | 63.27 | 60.95 | 61.75 | 934K | +1.43% |
| 2026-04-10 | 61.11 | 61.41 | 60.20 | 60.88 | 842K | -1.30% |
| 2026-04-09 | 59.93 | 61.90 | 59.20 | 61.68 | 1.18M | +2.63% |
| 2026-04-08 | 62.79 | 62.79 | 60.04 | 60.10 | 1.28M | -0.97% |
| 2026-04-07 | 59.80 | 61.00 | 58.51 | 60.69 | 1.03M | +1.45% |
| 2026-04-06 | 57.78 | 59.94 | 57.47 | 59.82 | 1.01M | +2.47% |
| 2026-04-02 | 57.42 | 58.77 | 56.83 | 58.38 | 935K | -0.21% |
| 2026-04-01 | 58.11 | 59.69 | 57.46 | 58.50 | 2.49M | +0.67% |
| 2026-03-31 | 56.47 | 58.80 | 56.21 | 58.11 | 1.86M | +5.73% |
| 2026-03-30 | 53.33 | 55.15 | 52.74 | 54.96 | 1.05M | +3.39% |
| 2026-03-27 | 54.72 | 55.52 | 52.89 | 53.16 | 953K | -2.83% |
| 2026-03-26 | 55.06 | 56.40 | 54.64 | 54.71 | 977K | -2.15% |
See PCVX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PCVX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PCVX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPCVX — Frequently Asked Questions
Quick answers to the most common questions about buying PCVX stock.
How has PCVX stock performed recently?
PCVX returned +77.5% over the past year, beating its 5-year annualized CAGR of +23.9%. The stock trades above its 200-day moving average, confirming the uptrend.
What is PCVX's all-time high price?
Vaxcyte, Inc. reached $121.06 on 2024-09-19. The 52-week high is $65.00. Current 1-year return of +77.5% places the stock closer to historical peaks.
Where can I download PCVX historical price data?
This page provides PCVX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2020-2026, downloadable in CSV format.